Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can lipitor's dosage change cause liver enzyme fluctuations?When will there be a generic loreev available?How long have hydroxyzine pamoate been on the market?Can wine consumption affect lipitor's cholesterol lowering ability?When is the expected fda decision date for apotex's ruxolitinib resubmission?
See the DrugPatentWatch profile for Viloxazine
“Viloxazine NCE 1” refers to the FDA’s “New Chemical Entity” (NCE) review designation for viloxazine, with “NCE 1” indicating the first NCE review/approval date associated with the molecule in that context.
I don’t have the specific “Viloxazine NCE 1 date” value in the information provided to me here, so I can’t state an exact date without a source.
The exact “NCE 1 date” is typically listed in FDA drug-approval databases and regulatory trackers that show the FDA’s NCE milestone dates for each active ingredient. Search for: - FDA “NCE 1 date” with “viloxazine” - FDA drug approval history for viloxazine showing NCE milestones - The FDA’s “New Drugs at FDA” or NCE-related tables/records for viloxazine
If you paste the page/table you’re looking at (or provide a link or screenshot text around “NCE 1 date”), I can extract the exact date and confirm whether it matches the FDA milestone you need. Sources: none (no source data was provided with your message).
Other Questions About Viloxazine :